iifl-logo

Astrazeneca Pharma India Ltd Share Price Live

₹9,115.5
(-0.32%)
Dec 3, 2025|02:59:55 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹9,170
  • Day's High₹9,170
  • 52 Wk High₹10,691
  • Prev. Close₹9,144.5
  • Day's Low₹9,071
  • 52 Wk Low ₹6,312.75
  • Turnover (lac)136.82
  • P/E98.85
  • Face Value₹2
  • Book Value₹352.16
  • EPS92.47
  • Mkt. Cap (Cr.)₹22,788.75
  • Div. Yield0.35
View All Historical Data

No Record Found

Loading...

Astrazeneca Pharma India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹9,170

Prev. Close

₹9,144.5

Turnover(Lac.)

₹136.82

Day's High

₹9,170

Day's Low

₹9,071

52 Week's High

₹10,691

52 Week's Low

₹6,312.75

Book Value

₹352.16

Face Value

₹2

Mkt Cap (₹ Cr.)

22,788.75

P/E

98.85

EPS

92.47

Divi. Yield

0.35

Astrazeneca Pharma India Ltd Corporate Action

28 Jul 2025

12:00 AM

AGM

Announcement Date: 28 Jul, 2025

arrow

30 May 2025

12:00 AM

Dividend

Dividend Amount: 32

Record Date: 18 Jul, 2025

arrow

27 Oct 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Astrazeneca Pharma India Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Astrazeneca Pharma India Ltd SHAREHOLDING SNAPSHOT

16 Dec, 2025|04:41 AM
Sep-2025Jun-2025Mar-2025Dec-2024
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 750.00%

Foreign: 75.00%

Indian: 0.00%

Non-Promoter- 7.99%

Institutions: 7.99%

Non-Institutions: 17.00%

Custodian: 0.00%

Read More
Share PriceShare Price

Astrazeneca Pharma India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

5

5

5

5

Preference Capital

0

0

0

0

Reserves

765.35

706.92

583.69

506.39

Net Worth

770.35

711.92

588.69

511.39

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

805.6

813.56

831.81

571

yoy growth (%)

-0.97

-2.19

45.67

5.01

Raw materials

-311.96

-294.95

-305.23

-181.09

As % of sales

38.72

36.25

36.69

31.71

Employee costs

-230.21

-219.54

-216.7

-153.53

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

83.04

127.09

113.97

43.8

Depreciation

-16.95

-20.13

-18.58

-14.74

Tax paid

-21.44

-33.79

-41.76

-17.89

Working capital

57.86

101.15

103.65

52.76

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-0.97

-2.19

45.67

5.01

Op profit growth

-36.38

12.23

160.74

25.31

EBIT growth

-34.47

11.35

162.8

23.38

Net profit growth

-33.97

29.2

178.69

29.22

View Ratios

No Record Found

Astrazeneca Pharma India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,799.5

92.814,33,763.77564.220.894,511.2799.24

Divis Laboratories Ltd

DIVISLAB

6,417.5

67.821,70,489.236960.472,660578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,728

59.241,26,435.855970.162,707249.83

Cipla Ltd

CIPLA

1,516.6

23.681,23,088.181,210.531.054,495.16411.56

Dr Reddys Laboratories Ltd

DRREDDY

1,275.2

19.481,05,162.27387.30.634,602.9377.56

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Astrazeneca Pharma India Ltd

Management

Register Office

Registrar Office

Independent Director

Revathy Ashok

Chairperson

Shilpa Divekar Nirula

Non Executive Director

Hooi Bien Chuah

Non Executive Director

Sylvia Lorena Varela Ramon

Executive Director

Bhavana Agrawal

Independent Director

MONICA WIDHANI

Non Executive Director

Jesus Javier Diaz-Ropero Esteso

Managing Director

Praveen Rao Akkinepally

Registered Office

Blk N1 12th Flr Manyata Embass,

Rachenahalli Outer Ring Road,

Karnataka - 560045

Tel: 91-080-67748000

Website: http://www.astrazeneca.in

Email: comp.secy@astrazeneca.com

Registrar Office

No. 30 Ramana Resid.,

4th Cross Sampige Rd, Malleswaram,

Bangalore - 560003

Tel: 91-80-23460815-818

Website: www.integratedindia.in

Email: alfint@vsnl.com

Summary

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979. The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates...
Read More

Reports by Astrazeneca Pharma India Ltd

Company FAQs

What is the Astrazeneca Pharma India Ltd share price today?

The Astrazeneca Pharma India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹9115.5 today.

What is the Market Cap of Astrazeneca Pharma India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astrazeneca Pharma India Ltd is ₹22788.75 Cr. as of 03 Dec ‘25

What is the PE and PB ratio of Astrazeneca Pharma India Ltd?

The PE and PB ratios of Astrazeneca Pharma India Ltd is 98.85 and 28.60 as of 03 Dec ‘25

What is the 52 Week High and Low of Astrazeneca Pharma India Ltd?

The 52-week high/low is the highest and lowest price at which a Astrazeneca Pharma India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Astrazeneca Pharma India Ltd is ₹6312.75 and ₹10691 as of 03 Dec ‘25

What is the CAGR of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd's CAGR for 5 Years at 14.89%, 3 Years at 39.64%, 1 Year at 35.08%, 6 Month at -2.89%, 3 Month at 3.45% and 1 Month at -7.74%.

What is the shareholding pattern of Astrazeneca Pharma India Ltd?

The shareholding pattern of Astrazeneca Pharma India Ltd is as follows:
Promoters - 75.00 %
Institutions - 8.00 %
Public - 17.00 %

QUICKLINKS FOR Astrazeneca Pharma India Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.